These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19917182)

  • 1. Development of alopecia areata after biological therapy with TNF-alpha Blockers: description of a case and review of the literature.
    Hernández MV; Nogués S; Ruiz-Esquide V; Alsina M; Cañete JD; Sanmartí R
    Clin Exp Rheumatol; 2009; 27(5):892-3. PubMed ID: 19917182
    [No Abstract]   [Full Text] [Related]  

  • 2. Worsening alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximab.
    Fabre C; Dereure O
    Dermatology; 2008; 216(2):185-6. PubMed ID: 18216487
    [No Abstract]   [Full Text] [Related]  

  • 3. Alopecia areata during etanercept therapy.
    Pan Y; Rao NA
    Ocul Immunol Inflamm; 2009; 17(2):127-9. PubMed ID: 19412875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alopecia areata universalis during off-label treatment with Infliximab in a patient with Behçet disease.
    Beccastrini E; Squatrito D; Emmi G; Fabbri P; Emmi L
    Dermatol Online J; 2010 Sep; 16(9):15. PubMed ID: 20875336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alopecia areata in a patient receiving infliximab.
    Ormaechea-Pérez N; López-Pestaña A; Muñagorri-Santos AI; Moreno AJ; Tuneu-Valls A
    Indian J Dermatol Venereol Leprol; 2013; 79(4):529-31. PubMed ID: 23760327
    [No Abstract]   [Full Text] [Related]  

  • 6. Alopecia areata following adalimumab.
    Kirshen C; Kanigsberg N
    J Cutan Med Surg; 2009; 13(1):48-50. PubMed ID: 19298772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alopecia areata during anti-TNF alpha therapy: Nine cases].
    Le Bidre E; Chaby G; Martin L; Perrussel M; Sassolas B; Sigal ML; Kaassis C; Lespessailles E; Nseir A; Estève E
    Ann Dermatol Venereol; 2011; 138(4):285-93. PubMed ID: 21497255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alopecia areata universalis elicited during treatment with adalimumab.
    Pelivani N; Hassan AS; Braathen LR; Hunger RE; Yawalkar N
    Dermatology; 2008; 216(4):320-3. PubMed ID: 18230980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alopecia areata universalis during treatment of rheumatoid arthritis with anti-TNF-alpha antibody (adalimumab).
    Chaves Y; Duarte G; Ben-Said B; Tebib J; Berard F; Nicolas JF
    Dermatology; 2008; 217(4):380. PubMed ID: 18849606
    [No Abstract]   [Full Text] [Related]  

  • 10. Concomitant alopecia areata and hypertrichosis after infliximab therapy: rara avis.
    Akarsu S; Tok F; Tekin L
    Acta Reumatol Port; 2013; 38(1):49-50. PubMed ID: 24131912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alopecia areata during treatment with biologic agents.
    Tosti A; Pazzaglia M; Starace M; Bellavista S; Vincenzi C; Tonelli G
    Arch Dermatol; 2006 Dec; 142(12):1653-4. PubMed ID: 17179002
    [No Abstract]   [Full Text] [Related]  

  • 12. Biologic agents and alopecia areata.
    Katoulis AC; Alevizou A; Bozi E; Georgala S; Mistidou M; Kalogeromitros D; Stavrianeas NG
    Dermatology; 2009; 218(2):184-5. PubMed ID: 19018127
    [No Abstract]   [Full Text] [Related]  

  • 13. Dermatitis herpetiformis in a patient receiving infliximab for ankylosing spondylitis.
    Marakli SS; Uzun S; Ozbek S; Tuncer I
    Eur J Dermatol; 2008; 18(1):88-9. PubMed ID: 18086603
    [No Abstract]   [Full Text] [Related]  

  • 14. [Polyarthritis flare in patient with ankylosing spondylitis treated with infliximab].
    Gutierrez M; Becciolini A; Bertolazzi C; Di Geso L; Tardella M; Ariani A; Filippucci E; Grassi W
    Reumatismo; 2010; 62(3):221-4. PubMed ID: 21052570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment patterns in the first year after initiating tumor necrosis factor blockers in real-world settings.
    Bonafede M; Fox KM; Watson C; Princic N; Gandra SR
    Adv Ther; 2012 Aug; 29(8):664-74. PubMed ID: 22886712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of alopecia areata universalis in a patient receiving adalimumab.
    Garcia Bartels N; Lee HH; Worm M; Burmester GR; Sterry W; Blume-Peytavi U
    Arch Dermatol; 2006 Dec; 142(12):1654-5. PubMed ID: 17179003
    [No Abstract]   [Full Text] [Related]  

  • 17. Abdominal pain in a patient with ankylosing spondylitis under treatment with infliximab.
    Cooper J; Flückiger B; Traichl B; Diener PA; Otto P; von Kempis J
    J Clin Rheumatol; 2009 Aug; 15(5):244-6. PubMed ID: 19590442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-nuclear antibodies, anti-DNA and C4 complement evolution in rheumatoid arthritis and ankylosing spondylitis treated with TNF-alpha blockers.
    Gonnet-Gracia C; Barnetche T; Richez C; Blanco P; Dehais J; Schaeverbeke T
    Clin Exp Rheumatol; 2008; 26(3):401-7. PubMed ID: 18578960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple paradoxical adverse events in a patient affected with ankylosing spondylitis treated with TNF blockers.
    Lo Nigro A; Ramonda R; Alaibac M; Modesti V; Punzi L
    Eur J Dermatol; 2011; 21(2):263-4. PubMed ID: 21411412
    [No Abstract]   [Full Text] [Related]  

  • 20. Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles.
    Ettefagh L; Nedorost S; Mirmirani P
    Arch Dermatol; 2004 Aug; 140(8):1012. PubMed ID: 15313825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.